VItamiN D treatIng Chronic heArT Failure (the Effect of Vitamin D Supplementation in Patients With Heart Failure)

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2023
VINDICATE 2 will be a randomised, placebo-controlled, parallel group, double-blind study of vitamin D versus placebo in otherwise optimally-managed patients with CHF due to LVSD and vitamin D deficiency (\<50nmol/L). The intervention will be a daily dose of 4000IU (100µg) per day or matching placebo for a minimum of 2 years and a maximum of 4 years.
Epistemonikos ID: aa8de2c8ef43938e8a7b0815850da32ee9135477
First added on: May 21, 2024